Back to AMLX
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA → AMLX
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$52K
Q3 2026
Peak value
$52K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $28K |
| Q1 2026 | $29K |
| Q2 2026 | $32K |
| Q3 2026 | $52K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $52K | 1.8K | — | — |
| Q2 2026 | $32K | 1.8K | — | — |
| Q1 2026 | $29K | 1.8K | — | — |
| Q4 2025 | $28K | 1.8K | — | — |
Other funds holding AMLX
$51.1M
$48.6M
$46.8M
$46.8M
$42.7M